1
|
Lee JK, Kim KW, Choi JY, Moon SY, Kim SG, Kim CH, Kim HM, Kwon YD, Kim YD, Lee DK, Min SK, Park IS, Park YW, Kook MS, Park HJ, Baek JA, Park JW, Kwon TG. Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. J Korean Assoc Oral Maxillofac Surg 2013; 39:9-13. [PMID: 24471011 PMCID: PMC3858159 DOI: 10.5125/jkaoms.2013.39.1.9] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2012] [Revised: 10/09/2012] [Accepted: 10/29/2012] [Indexed: 12/13/2022] Open
Abstract
Objectives Bisphosphonates (BP) are widely used in medicine for inhibiting bone resorption; however bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a major side effect of BP. To date, there have been no specific reports on the incidence of BRONJ among Koreans. This study investigated the preliminary results from a nationwide survey of BRONJ in the Departments of Oral and Maxillofacial Surgery (OMFS) at individual training hospitals. Materials and Methods A total of 15 OMFS departments (10 from dental schools, 4 from medical schools, and 1 from a dental hospital) participated in a multi-centric survey. This study assessed every BRONJ case diagnosed between January 2010 and December 2010. The patient age and BP type were evaluated. Results A total of 254 BRONJ cases were collected. The majority of BRONJ cases were associated with oral BP therapy, while 21.8% of the cases were associated with intravenous administration. Alendronate was the drug most frequently related to BRONJ (59.2% of cases), followed by risedronate (14.3%) and zolendronate (17.0%). The average age of BRONJ patients was 70.0±10.1 years, with a range of 38-88 years of age. With the number of BP patients in Korea reported to be around 600,000 in 2008, the estimated incidence of BRONJ is at least 0.04% or 1 per 2,300 BP patients. Conclusion The results suggest that the estimated incidence of BRONJ in Korea is higher than the incidence of other countries. Future prospective studies should be carried out to investigate the exact epidemiological characteristics of BRONJ in Korea.
Collapse
Affiliation(s)
| | | | - Jin-Young Choi
- Board of Bone Bank, Seoul National University, Seoul, Korea
| | | | - Su-Gwan Kim
- Board of Bone Bank, Chosun University, Gwangju, Korea
| | - Chul-Hwan Kim
- Board of Bone Bank, Dankook University, Cheonan, Korea
| | - Hyeon-Min Kim
- Board of Bone Bank, Gachon University Gil Medical Center, Incheon, Korea
| | - Yong-Dae Kwon
- Board of Bone Bank, Kyung Hee University, Seoul, Korea
| | - Yong-Deok Kim
- Board of Bone Bank, Pusan National University, Yangsan, Korea
| | - Dong-Keun Lee
- Board of Bone Bank, Daejeon Sun Hospital, Daejeon, Korea
| | - Seung-Ki Min
- Board of Bone Bank, Wonkwang University, Iksan, Korea
| | - In-Sook Park
- Board of Bone Bank, Catholic University of Daegu, Daegu, Korea
| | - Young-Wook Park
- Board of Bone Bank, Gangneung-Wonju National University, Gangneung, Korea
| | - Min-Suk Kook
- Board of Bone Bank, Chonnam National University, Gwangju, Korea
| | - Hong-Ju Park
- Board of Bone Bank, Chonnam National University, Gwangju, Korea
| | - Jin-A Baek
- Board of Bone Bank, Chonbuk National University, Jeonju, Korea
| | - Jun-Woo Park
- Board of Bone Bank, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea
| | - Tae-Geon Kwon
- Board of Bone Bank, Kyungpook National University, Daegu, Korea
| |
Collapse
|